Terms: = Liver cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
9 results:
1. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
[TBL] [Abstract] [Full Text] [Related]
2. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.
Peduzzi G; Archibugi L; Katzke V; Gentiluomo M; Capurso G; Milanetto AC; Gazouli M; Goetz M; Brenner H; Vermeulen RCH; Talar-Wojnarowska R; Vanella G; Tavano F; Lucchesi M; Mohelnikova-Duchonova B; Chen X; Kiudelis V; Hegyi P; Oliverius M; Stocker H; Stornello C; Vodickova L; Souček P; Neoptolemos JP; Testoni SGG; Morelli L; Lawlor RT; Basso D; Izbicki JR; Ermini S; Kupcinskas J; Pezzilli R; Boggi U; van Laarhoven HWM; Szentesi A; Erőss B; Capretti G; Schöttker B; Skieceviciene J; Aoki MN; van Eijck CHJ; Cavestro GM; Canzian F; Campa D
Sci Rep; 2022 Oct; 12(1):18100. PubMed ID: 36302831
[TBL] [Abstract] [Full Text] [Related]
3. SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα.
Naiman S; Huynh FK; Gil R; Glick Y; Shahar Y; Touitou N; Nahum L; Avivi MY; Roichman A; Kanfi Y; Gertler AA; Doniger T; Ilkayeva OR; Abramovich I; Yaron O; Lerrer B; Gottlieb E; Harris RA; Gerber D; Hirschey MD; Cohen HY
Cell Rep; 2019 Dec; 29(12):4127-4143.e8. PubMed ID: 31851938
[TBL] [Abstract] [Full Text] [Related]
4. Rational discovery of novel type-III FTF antagonists to competitively suppress TIF-2 coactivation in liver cancer.
Xu L; Chen Z; Shao K; Wang Y; Cui L; Guo N
J Recept Signal Transduct Res; 2019 Aug; 39(4):304-311. PubMed ID: 31755335
[TBL] [Abstract] [Full Text] [Related]
5. [Angiofibroma of soft tissue: a clinicopathologic analysis of 24 cases].
Xu XL; Liu JG; Sun M; Yu L; Liu QY; Bai QM; Wu LJ; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):616-621. PubMed ID: 30107667
[No Abstract] [Full Text] [Related]
6. SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
Suresh S; Durakoglugil D; Zhou X; Zhu B; Comerford SA; Xing C; Xie XJ; York B; O'Donnell KA
PLoS Genet; 2017 Mar; 13(3):e1006650. PubMed ID: 28273073
[TBL] [Abstract] [Full Text] [Related]
7. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for ncoa2/Src-2 in liver cancer.
O'Donnell KA; Keng VW; York B; Reineke EL; Seo D; Fan D; Silverstein KA; Schrum CT; Xie WR; Mularoni L; Wheelan SJ; Torbenson MS; O'Malley BW; Largaespada DA; Boeke JD
Proc Natl Acad Sci U S A; 2012 May; 109(21):E1377-86. PubMed ID: 22556267
[TBL] [Abstract] [Full Text] [Related]
8. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
Matthews J; Wihlén B; Thomsen J; Gustafsson JA
Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
[TBL] [Abstract] [Full Text] [Related]
9. Molecular cloning of xSRC-3, a novel transcription coactivator from Xenopus, that is related to AIB1, p/CIP, and tif2.
Kim HJ; Lee SK; Na SY; Choi HS; Lee JW
Mol Endocrinol; 1998 Jul; 12(7):1038-47. PubMed ID: 9658407
[TBL] [Abstract] [Full Text] [Related]
